Phillip Buckhaults to Cell Line, Tumor
This is a "connection" page, showing publications Phillip Buckhaults has written about Cell Line, Tumor.
Connection Strength
0.354
-
PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids. Proc Natl Acad Sci U S A. 2018 05 29; 115(22):E5066-E5075.
Score: 0.105
-
Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients. PLoS One. 2013; 8(3):e58731.
Score: 0.074
-
A gene expression classifier of node-positive colorectal cancer. Neoplasia. 2009 Oct; 11(10):1074-83.
Score: 0.058
-
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020 05 15; 11(1):2416.
Score: 0.030
-
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer. Clin Cancer Res. 2018 12 15; 24(24):6433-6446.
Score: 0.027
-
Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen. Sci Rep. 2017 02 22; 7:43023.
Score: 0.024
-
Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res. 2009 Aug; 22(4):435-44.
Score: 0.014
-
The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13; 314(5797):268-74.
Score: 0.012
-
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res. 2004 Apr 01; 10(7):2386-92.
Score: 0.010